Veterinary Medicines

Animal health as a distinct regulated category

Veterinary medicines are regulated separately from human medicines in almost every market, with their own registration routes, their own labelling rules and, for food-producing animals, an additional layer of requirements around residues in meat, milk, eggs and honey. Importers who assume the human pharmaceutical pathway applies find the process does not fit. VP Global Exim sources veterinary products from licensed Indian manufacturers and handles the documentation this category specifically requires.

Our role is the same limited one as elsewhere. We are a merchant exporter, not a manufacturer, not a veterinary practice and not a regulatory consultancy. We do not advise on the treatment of animals, the selection of products for conditions, dosing or withdrawal decisions, and we make no claims about safety or efficacy. Those judgements belong to qualified veterinary professionals in your market. We source to a specification and manage the export.

The ranges we can source include products for livestock including cattle, sheep and goats, poultry products, aquaculture products, companion animal products for dogs and cats, and feed supplements and nutritional products for animals. Dosage forms include oral powders and solutions, boluses and tablets, injectables, topical and pour-on preparations, intramammary preparations, and premixes for feed incorporation, subject to the manufacturer holding the relevant facility approvals.

Species, indication and route are part of the identity

A veterinary product is defined by the species it is approved for as much as by its formulation. The same active can be authorised for one species and not another, at different doses, by different routes and with different withdrawal periods. A product approved for cattle is not thereby approved for sheep, and using or labelling it as though it were is both a regulatory and an animal safety problem.

We therefore specify target species, indication as approved, route of administration, dose form and strength explicitly for every product, and we require the manufacturer's documentation to state them. Where a buyer's requirement is for a species the product is not approved for in their market, we flag it rather than supplying and leaving the problem at destination.

Companion animal and food-producing animal products face different regulatory treatment, and the distinction matters commercially as well. Companion animal products often move through veterinary practices and pet retail with different pack sizes and presentation; food-producing animal products carry residue and withdrawal obligations that dominate their documentation. A range covering both needs to be planned as two different projects.

Species safety warnings are a specific area we do not improvise on. Some actives are seriously toxic to particular species, and labelling must carry the warnings the destination market requires. We ensure approved warning text is reproduced accurately and completely, and we do not edit or condense it for packaging convenience.

Withdrawal periods and residue requirements

For any product used in food-producing animals, the withdrawal period - the interval that must elapse between last treatment and the animal's produce entering the food chain - is the defining regulatory feature. It is set to ensure residues fall below the maximum residue limit for that active in that tissue, and it differs by species, by route, by formulation and by market. It is not a property that transfers between markets or products.

We require the withdrawal period to be stated in the manufacturer's documentation and on the labelling for every food-producing animal product, for each species and route the product covers, together with the data supporting it. Where the destination market has established its own withdrawal period or maximum residue limit for that active, the destination's figure governs, and we confirm it rather than carrying over the origin market's number.

Some actives are prohibited in food-producing animals in some markets entirely, and some are prohibited in all species. Those prohibitions differ between jurisdictions and change over time. We check the intended actives against the destination market's prohibited and restricted lists before quoting, because supplying a prohibited active into a food chain is a serious matter rather than a compliance technicality.

Residue monitoring in destination markets is real and consequential: a residue detection can trigger enforcement against the producer, the veterinarian and the importer, and in some cases trade restrictions on a whole export sector. That is why we treat withdrawal documentation as non-negotiable rather than as paperwork, and why we will not supply a food-producing animal product without it.

Manufacturer selection and facility approvals

Veterinary manufacture requires its own licensing, and for some product types dedicated facilities. We verify that the unit holds a valid manufacturing licence covering veterinary products and the specific dosage forms, that its GMP certification is current and covers the relevant facility and section, and that it holds any additional approval your market recognises for veterinary imports.

Facility segregation matters more here than buyers often realise. Certain actives require dedicated production areas to prevent cross-contamination, and cross-contamination of a feed premix or an oral product with a prohibited or species-toxic active is a genuine hazard. We assess segregation, cleaning validation and cross-contamination controls during manufacturer selection, and we ask for the evidence rather than the assurance.

Export documentation capability is assessed alongside technical capability. A manufacturer may produce excellent product for the domestic market and be unable to supply the dossier, stability data, withdrawal justification or certificates that an overseas veterinary registration requires. We establish that capability in advance, since it determines whether a registration project is feasible at all.

Registration, import licensing and responsibilities

Veterinary medicines generally require registration or marketing authorisation in the destination market before import and sale, and the importer normally requires a specific licence covering veterinary products. The registration route, the data requirements and the timeline are distinct from the human pharmaceutical route, and in many markets the competent authority is a different body altogether.

Those responsibilities rest with you. Obtaining the import licence, securing registration, appointing any required local representative, and complying with distribution, record-keeping, prescription-status and adverse-event reporting obligations are the importer's duties. We provide manufacturer-side documentation - dossier, licences, GMP certification, specifications, stability data, withdrawal justification, certificates of analysis and free sale or equivalent certificates - and coordinate with the manufacturer on regulatory queries.

Prescription status is worth settling early because it shapes the commercial model. Many veterinary products are prescription-only and can be supplied only through veterinary channels; others are available for general sale. Status differs by market and by product, and assuming general-sale status because a product is sold that way domestically is a common and costly error.

We supply only where the required authorisations are in place, and we decline requests to supply veterinary medicines to unlicensed buyers, to route product to avoid registration, or to supply actives prohibited in the destination market or in the intended species. We also decline where a food-producing animal product cannot be supplied with proper withdrawal documentation.

Quality documentation and batch release

Each shipment carries batch-specific documentation. A Certificate of Analysis states tested parameters against the registered or agreed specification with actual measured values, covering identification and assay of actives, related substances where applicable, uniformity and dissolution on solid forms, sterility and endotoxins on injectables, microbiological limits, and physical parameters appropriate to the dosage form.

Premixes and feed-incorporated products carry their own requirements, including homogeneity of the active through the premix, carry-over and cross-contamination controls, and stability of the active through feed processing where relevant. Homogeneity is verified by multi-point sampling rather than assumed, because an inhomogeneous premix delivers the wrong dose to individual animals in both directions.

Independent verification is available where your programme requires it: third-party laboratory testing on production samples, pre-shipment inspection by a nominated agency, and labelling verification against approved artwork. For food-producing animal products we recommend verifying the withdrawal statement and species labelling on the actual printed packaging before the consignment ships, since an error there has consequences well beyond the shipment.

Packaging, storage and cold chain

Veterinary packaging must survive farm and field conditions as well as satisfy regulation. Primary packaging is specified for compatibility and durability - HDPE containers with tamper-evident closures for oral liquids and powders, multi-dose vials with appropriate stoppers for injectables, sachets and bags for premixes, and applicators for pour-on and topical products. Pack sizes are typically larger than human equivalents and are specified to the herd or flock size the market serves.

Labelling must remain legible in use, which for farm products means resistance to moisture, handling and sunlight. Labels carry the species, indication, dose, route, withdrawal period, warnings, batch and expiry, storage conditions, prescription status and manufacturer and importer details in the required languages. We verify artwork against the destination requirement list before printing.

Storage conditions are specified and, where a product requires refrigeration, a validated cold chain applies with monitored transport and data-logger records supplied. Vaccines and biological products have particularly strict requirements and we handle them only where the full chain, including the buyer's storage capability at destination, can be evidenced. A cold chain that ends at an unrefrigerated store has achieved nothing.

Starting a veterinary enquiry

Tell us the product, its formulation and strength, the target species and indication, the route and dose form, the pack presentation and quantity, and your destination market. Then tell us whether you hold a veterinary import licence, whether the product is registered there, and whether the species involved are food-producing. That last point determines the whole documentation burden.

We will check the actives against your market's prohibited and restricted lists for the intended species, confirm whether withdrawal periods and maximum residue limits are established there, propose licensed manufacturers with their approval and facility status, set out the documentation package, and quote with lead times and a realistic view of the registration pathway.

Where a requirement cannot be met compliantly - a prohibited active, an unapproved species, or a food-producing animal product without withdrawal data - we will tell you at that stage rather than after commitment. In a category where an error can affect a food chain and an importer's licence, that is the only sensible way to start.